» Articles » PMID: 20139967

A Nonviral Minicircle Vector for Deriving Human IPS Cells

Overview
Journal Nat Methods
Date 2010 Feb 9
PMID 20139967
Citations 326
Authors
Affiliations
Soon will be listed here.
Abstract

Owing to the risk of insertional mutagenesis, viral transduction has been increasingly replaced by nonviral methods to generate induced pluripotent stem cells (iPSCs). We report the use of 'minicircle' DNA, a vector type that is free of bacterial DNA and capable of high expression in cells, for this purpose. Here we use a single minicircle vector to generate transgene-free iPSCs from adult human adipose stem cells.

Citing Articles

Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects.

Alidadi M, Barzgar H, Zaman M, Paevskaya O, Metanat Y, Khodabandehloo E Front Cell Dev Biol. 2024; 12:1491282.

PMID: 39624236 PMC: 11609223. DOI: 10.3389/fcell.2024.1491282.


Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.

Lin Y, Ku C, Wuputra K, Liu C, Wu D, Satou M Int J Mol Sci. 2024; 25(10).

PMID: 38791215 PMC: 11120835. DOI: 10.3390/ijms25105177.


"Time Is out of Joint" in Pluripotent Stem Cells: How and Why.

Agriesti F, Cela O, Capitanio N Int J Mol Sci. 2024; 25(4).

PMID: 38396740 PMC: 10889767. DOI: 10.3390/ijms25042063.


Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.

Klymenko V, Gonzalez Martinez O, Zarbin M Stem Cells Transl Med. 2024; 13(4):317-331.

PMID: 38394392 PMC: 11016854. DOI: 10.1093/stcltm/szae004.


Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation.

Netsrithong R, Garcia-Perez L, Themeli M Front Immunol. 2024; 14:1325209.

PMID: 38283344 PMC: 10811463. DOI: 10.3389/fimmu.2023.1325209.


References
1.
Chen Z, He C, Kay M . Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther. 2005; 16(1):126-31. DOI: 10.1089/hum.2005.16.126. View

2.
Munz C, Bickham K, Subklewe M, Tsang M, Chahroudi A, Kurilla M . Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. J Exp Med. 2000; 191(10):1649-60. PMC: 2193162. DOI: 10.1084/jem.191.10.1649. View

3.
Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G, Cook E . Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009; 136(5):964-77. PMC: 2787236. DOI: 10.1016/j.cell.2009.02.013. View

4.
Kim D, Kim C, Moon J, Chung Y, Chang M, Han B . Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009; 4(6):472-6. PMC: 2705327. DOI: 10.1016/j.stem.2009.05.005. View

5.
Zhou H, Wu S, Joo J, Zhu S, Han D, Lin T . Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 2009; 4(5):381-4. PMC: 10182564. DOI: 10.1016/j.stem.2009.04.005. View